Navigation Links
Life Technologies to Present at Upcoming Investment Conferences in February
Date:1/26/2012

CARLSBAD, Calif., Jan. 26, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it will webcast the company's presentations at the following upcoming investment conferences in February.

(Logo: http://photos.prnewswire.com/prnh/20110216/MM49339LOGO)

Life Technologies will present at the Leerink Swann 2012 Global Healthcare Conference on Thursday, February 16 at 8:30 a.m. ET.

Life Technologies will also present at the 2012 RBC Capital Markets' Global Healthcare Conference on Wednesday, February 29 at 9:30 a.m. ET.

David Hoffmeister, Life Technologies' Senior Vice President and Chief Financial Officer, will present at the conferences on behalf of the company. These webcasts may be accessed in the Investor Relations section of the Life Technologies website at ir.lifetechnologies.com/events.cfm.

Additionally, Life Technologies will attend the 2012 Citi Global Health Care Conference on Tuesday, February 28.

About Life Technologies

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, GIBCO, Ambion, Molecular Probes and Taqman products. Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 4,000 patents and exclusive licenses. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.

Contact Information:

Investor Relations
760-603-7208
ir@lifetech.com


'/>"/>
SOURCE Life Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Life Technologies Partners With DaAn Gene to Develop and Commercialize Molecular Diagnostic Assays in China
2. Life Technologies Announces Redemption of 1.5% Convertible Senior Notes Due 2024
3. Ion Proton™ Sequencer - Inventor, Dr. M. Jonathan Rothberg and Life Technologies CEO, Greg Lucier, Available for Interviews at CES Today
4. Life Technologies Plant in Austin, Texas Named One of IndustryWeeks Top Ten Best Plants for 2011
5. Life Technologies Receives AFNOR Validation for Tests Designed to Detect Listeria Contamination in Food Samples
6. Cytogenetics - Technologies, Markets and Companies
7. BioStorage Technologies Partners with Susan G. Komen for the Cure Tissue Bank at IU Simon Cancer Center to Raise Money and Awareness for Breast Cancer Research
8. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
9. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
10. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
11. BioStorage Technologies Appoints New Member to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ... immunotherapies, will host a Key Opinion Leader event to ... an oral and poster presentation at the upcoming 2017 ... The KOL event will be held in-person and via ... EST / 9:00 AM PST at the Lotte New ...
(Date:2/23/2017)... JOSE, Calif. , Feb. 23, 2017 /PRNewswire/ ... exclusive license for two key immunotherapy technologies from ... first technology provides a method to monitor a ... such as PD-L1 and CTLA-4.  The second license ... if a patient is likely to have an ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... today that in a published evaluation of multiple immunoassay-based threat detection technologies ... of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to ...
(Date:2/23/2017)... Aviva Systems Biology Corporation (ASB) which ... GenWay Biotech Incorporated, a protein solutions and applications ... for both the research and diagnostic markets. ... capabilities for both entities. GenWay,s 18 years of experience ... complement ASB,s objective to become a leading provider ...
Breaking Biology Technology:
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
(Date:2/7/2017)... February 7, 2017 Ipsidy Inc. ... Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a provider ... processing services, is pleased to announce the following changes ... Effective January 31, 2017, Philip D. Beck ... CEO and President.  An experienced payment industry professional and ...
Breaking Biology News(10 mins):